01—History
Operating Cash Flow History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- −$1.87B
4 older moves run past ±150% (largest −596.7%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is operating cash flow?
Operating cash flow can be defined as the cash generated from a company's normal business operations, reflecting the ability to generate cash from core activities.
What is Moderna, Inc.'s current operating cash flow?
Moderna, Inc. (MRNA) annual operating cash flow for 2025 was $-1.87B, a 37.65% increase from 2024. Moderna, Inc. operating cash flow for the quarter ending March 31, 2026 was $-630.0M.
What was Moderna, Inc.'s operating cash flow in 2024?
Moderna, Inc. annual operating cash flow for 2024 was $-3.00B, a 3.66% increase from 2023.
What was Moderna, Inc.'s operating cash flow in 2023?
Moderna, Inc. annual operating cash flow for 2023 was $-3.12B, a 162.60% decline from 2022.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)